1887
Preview this article:
Zoom in
Zoomout

Chlamydial vaccine development, Page 1 of 1

| /docserver/preview/fulltext/jmm/52/7/JMM5207.537-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.05093-0
2003-07-01
2019-11-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/52/7/JM520701.html?itemId=/content/journal/jmm/10.1099/jmm.0.05093-0&mimeType=html&fmt=ahah

References

  1. Antex Biologics ( 2003;). Antex files Chlamydia investigational new drug application with FDA. STD vaccine clinical trial. Press release, 3 February 2003. http://www.antexbiologics.com/news_pr/pr030203.phtm
  2. Buzoni-Gatel, D., Guilloteau, L., Bernard, F., Bernard, S., Chardes, T. & Rocca, A. ( 1992;). Protection against Chlamydia psittaci in mice conferred by Lyt-2+ T cells. Immunology 77, 284–288.
    [Google Scholar]
  3. de la Maza, M. A. & de la Maza, L. M. ( 1995;). A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections. Vaccine 13, 119–127.[CrossRef]
    [Google Scholar]
  4. Entrican, G., Buxton, D. & Longbottom, D. ( 2001;). Chlamydial infection in sheep: immune control versus fetal pathology. J R Soc Med 94, 273–277.
    [Google Scholar]
  5. Fling, S. P., Sutherland, R. A., Steele, L. N., Hess, B., D'Orazio, S. E. F., Maisonneuve, J., Lampe, M. F., Probst, P. & Starnbach, M. N. ( 2001;). CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis. Proc Natl Acad Sci U S A 98, 1160–1165.[CrossRef]
    [Google Scholar]
  6. Gentschev, I., Dietrich, G., Spreng, S., Pilgrim, S., Stritzker, J., Kolb-Maurer, A. & Goebel, W. ( 2002;). Delivery of protein antigens and DNA by attenuated intracellular bacteria. Int J Med Microbiol 291, 577–582.
    [Google Scholar]
  7. Hayes, L. J., Conlan, J. W., Everson, J. S., Ward, M. E. & Clarke, I. N. ( 1991;). Chlamydia trachomatis major outer membrane protein epitopes expressed as fusions with LamB in an attenuated aroA strain of Salmonella typhimurium; their application as potential immunogens. J Gen Microbiol 137, 1557–1564.[CrossRef]
    [Google Scholar]
  8. Henderson, I. R. & Lam, A. C. ( 2001;). Polymorphic proteins of Chlamydia spp.–autotransporters beyond the Proteobacteria. Trends Microbiol 9, 573–578.[CrossRef]
    [Google Scholar]
  9. Herring, A. J., Jones, G. E., Dunbar, S. M., Nettleton, P. F., Fitzgerald, T. A., Anderson, I. E., Chapman, S. N. & Wilson, T. M. A. ( 1998;). Recombinant vaccines against Chlamydia psittaci –an overview of results using bacterial expression and a new approach using a plant virus ‘overcoat’ system. In Proceedings of the Ninth International Symposium on Human Chlamydial Infection, pp. 434–437. Edited by R. S. Stephens, G. I. Byrne, G. Christiansen & 7 others. San Francisco: International Chlamydia Symposium.
  10. Hsia, R. C., Pannekoek, Y., Ingerowski, E. & Bavoil, P. M. ( 1997;). Type III secretion genes identify a putative virulence locus of Chlamydia. Mol Microbiol 25, 351–359.[CrossRef]
    [Google Scholar]
  11. Igietseme, J. U. ( 2002;). Functional immunobiology of Chlamydia: vaccine perspective. In Proceedings of the Tenth International Symposium on Human Chlamydial Infections, pp. 223–232. Edited by J. Schachter, G. Christiansen, I. N. Clarke & 11 others. San Francisco: International Chlamydia Symposium.
  12. Lampe, M. F., Ballweber, L. M. & Stamm, W. E. ( 1998a;). Cloning and sequence analysis of a putative cytolysin from Chlamydia trachomatis. In Proceedings of the Ninth International Symposium on Human Chlamydial Infection, pp. 555–558. Edited by R. S. Stephens, G. I. Byrne, G. Christiansen & 7 others. San Francisco: International Chlamydia Symposium.
  13. Lampe, M. F., Wilson, C. B., Bevan, M. J. & Starnbach, M. N. ( 1998b;). Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection. Infect Immun 66, 5457–5461.
    [Google Scholar]
  14. Longbottom, D. & Coulter, L. J. ( 2003;). Animal chlamydioses and zoonotic implications. J Comp Pathol 128, 217–244.[CrossRef]
    [Google Scholar]
  15. Longbottom, D., Findlay, J., Vretou, E. & Dunbar, S. M. ( 1998a;). Immunoelectron microscopic localisation of the OMP90 family on the outer membrane surface of Chlamydia psittaci. FEMS Microbiol Lett 164, 111–117.[CrossRef]
    [Google Scholar]
  16. Longbottom, D., Russell, M., Dunbar, S. M., Jones, G. E. & Herring, A. J. ( 1998b;). Molecular cloning and characterization of the genes coding for the highly immunogenic cluster of 90-kilodalton envelope proteins from the Chlamydia psittaci subtype that causes abortion in sheep. Infect Immun 66, 1317–1324.
    [Google Scholar]
  17. Lu, H. & Zhong, G. M. ( 1999;). Interleukin-12 production is required for chlamydial antigen-pulsed dendritic cells to induce protection against live Chlamydia trachomatis infection. Infect Immun 67, 1763–1769.
    [Google Scholar]
  18. Moore, T., Ananaba, G. A., Bolier, J., Bowers, S., Belay, T., Eko, F. O. & Igietseme, J. U. ( 2002;). Fc receptor regulation of protective immunity against Chlamydia trachomatis. Immunology 105, 213–221.[CrossRef]
    [Google Scholar]
  19. Murdin, A. D., Su, H., Manning, D. S., Klein, M. H., Parnell, M. J. & Caldwell, H. D. ( 1993;). A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic. Infect Immun 61, 4406–4414.
    [Google Scholar]
  20. Murdin, A. D., Dunn, P., Sodoyer, R., Wang, J., Caterini, J., Brunham, R. C., Aujame, L. & Oomen, R. ( 2000;). Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection. J Infect Dis 181 (Suppl. 3), S544–S551.[CrossRef]
    [Google Scholar]
  21. Pal, S., Barnhart, K. M., Wei, Q., Abai, A. M., Peterson, E. M. & de la Maza, L. M. ( 1999;). Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge. Vaccine 17, 459–465.[CrossRef]
    [Google Scholar]
  22. Rank, R. G. ( 1999;). Models of immunity. In Chlamydia: Intracellular Biology, Pathogenesis and Immunity, pp. 239–295. Edited by R. S. Stephens. Washington, DC: American Society for Microbiology.
  23. Rank, R. G. & Batteiger, B. E. ( 1989;). Protective role of serum antibody in immunity to chlamydial genital infection. Infect Immun 57, 299–301.
    [Google Scholar]
  24. Rank, R. G., White, H. J. & Barron, A. L. ( 1979;). Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect Immun 26, 573–579.
    [Google Scholar]
  25. Read, T. D., Brunham, R. C., Shen, C. & 22 other authors ( 2000;). Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res 28, 1397–1406.[CrossRef]
    [Google Scholar]
  26. Rockey, D. D., Lenart, J. & Stephens, R. S. ( 2000;). Genome sequencing and our understanding of chlamydiae. Infect Immun 68, 5473–5479.[CrossRef]
    [Google Scholar]
  27. Saikku, P. ( 1998;). Chlamydia pneumoniae –clinical spectrum. In Proceedings of the Ninth International Symposium on Human Chlamydial Infection, pp. 145–154. Edited by R. S. Stephens, G. I. Byrne, G. Christiansen & 7 others. San Francisco: International Chlamydia Symposium.
  28. Schachter, J. ( 1988;). Overview of human diseases. In Microbiology of Chlamydia, pp. 153–165. Edited by A. L. Barron. Boca Raton, FL: CRC Press.
  29. Shaw, J., Grund, V., Durling, L., Crane, D. & Caldwell, H. D. ( 2002;). Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4+ type 2 rather than type 1 immune response that is not protective. Infect Immun 70, 1097–1105.[CrossRef]
    [Google Scholar]
  30. Stagg, A. J. ( 1998;). Vaccines against Chlamydia: approaches and progress. Mol Med Today 4, 166–173.[CrossRef]
    [Google Scholar]
  31. Stephens, R. S., Kalman, S., Lammel, C. & 9 other authors ( 1998;). Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282, 754–759.[CrossRef]
    [Google Scholar]
  32. Storz, J. ( 1988;). Overview of animal diseases induced by chlamydial infections. In Microbiology of Chlamydia, pp. 167–192. Edited by A. L. Barron. Boca Raton, FL: CRC Press.
  33. Stuart, E. S., Tirrell, S. M. & MacDonald, A. B. ( 1987;). Characterization of an antigen secreted by Chlamydia-infected cell culture. Immunology 61, 527–533.
    [Google Scholar]
  34. Su, H., Feilzer, K., Caldwell, H. D. & Morrison, R. P. ( 1997;). Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect Immun 65, 1993–1999.
    [Google Scholar]
  35. Su, H., Messer, R., Whitmire, W., Fischer, E., Portis, J. C. & Caldwell, H. D. ( 1998;). Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable chlamydiae. J Exp Med 188, 809–818.[CrossRef]
    [Google Scholar]
  36. Turner, M. S. & Giffard, P. M. ( 1999;). Expression of Chlamydia psittaci- and human immunodeficiency virus-derived antigens on the cell surface of Lactobacillus fermentum BR11 as fusions to BspA. Infect Immun 67, 5486–5489.
    [Google Scholar]
  37. Vanrompay, D., Cox, E., Vandenbussche, F., Volckaert, G. & Goddeeris, B. ( 1999;). Protection of turkeys against Chlamydia psittaci challenge by gene gun-based DNA immunizations. Vaccine 17, 2628–2635.[CrossRef]
    [Google Scholar]
  38. Ward, M. E. ( 1999;). Mechanisms of disease. In Chlamydia: Intracellular Biology, Pathogenesis and Immunity, pp. 171–210. Edited by R. S. Stephens. Washington, DC: American Society for Microbiology.
  39. Zhang, D., Yang, X., Berry, J., Shen, C., McClarty, G. & Brunham, R. C. ( 1997;). DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection. J Infect Dis 176, 1035–1040.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.05093-0
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error